Alzheimer's Therapeutics Market Size, Emerging Trends and Overview to 2024: Hexa Reports

Hexa Reports

Market Research Reports and Insightful Company Profiles

Alzheimer's Therapeutics Market Analysis, Share and Size,

Trends, Industry Growth, Overview And Segment Forecasts

To 2024

The global alzheimer's therapeutics market is expected to reach USD 6.4 billion in 2024, according to a

new report by Grand View Research. Some primary factors driving the market growth includes rising

government initiatives in order to raise awareness levels among people.

Growing knowledge about the Alzheimer's disease (AD) and its high prevalence and incidence in

developing economies are few of the major drivers supporting the market growth. Several governments,

nonprofit, and private organizations worldwide are actively engaged in increasing people's awareness

regarding progressive AD, such as Alzheimer's Association, the Alzheimer's Society of Canada,

Alzheimer's Europe organization, and various other small organizations.

Browse Detail Report With TOC @

http://www.hexareports.com/report/alzheimer-s-therapeutics-market/details

Furthermore, the increased government funding for providing better care and support to the people

with partial dementia is another important factor anticipated to enlarge market growth. For instance,

organizations like Florida Department of Health, the National Institute of Health, and Alzheimer's

Association in partnership with other private and government organizations provide funds to the

research centers.

Hexa Reports

Market Research Reports and Insightful Company Profiles

The presence of various pipeline drugs is anticipated to provide the market with potential growth

opportunities. For instance, LMTX by TauRx Pharmaceutical Ltd.; idalopirdine (Lu AE58054) by Lundbeck;

crenezumab by AC Immune SA; and BAN2401 by Eisai

Moreover, novel therapeutics with minimal dosage requirement has been introduced resulting in costeffective alternatives, which is further expected to boost the market growth. For instance, Namzaric by...